Literature DB >> 29173157

In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.

Camille Richeval1,2, Thomas Gicquel3,4, Chloe Hugbart4, Brendan Le Dare4, Delphine Allorge1,2, Isabelle Morel3,4, Jean-Michel Gaulier1,2.   

Abstract

BACKGROUND: Identification of metabolites is of importance in the challenge of new psychoactive substances (NPS) as it could improve the detection window in biological matrices in clinical and forensic cases of intoxication. Considering the numerous and diverse NPS reported each year, producers increasingly appear today to be targeting non-controlled synthetic opioids, involving fentanyl derivatives such as furanyl fentanyl (Fu-F).
OBJECTIVE: This work aims to investigate and compare metabolites of Fu-F using two in vitro experimental approaches.
METHODS: CYP- and UGT-dependent metabolites of Fu-F were investigated by means of analyses of both human liver microsome (HLM) and hepatic (HepaRG) cell line incubates using liquid chromatography with high-resolution mass detection and, subsequently, compared and confronted to recently published data.
RESULTS: Seventeen Fu-F metabolites were produced and several metabolic pathways can be postulated. HLMs and HepaRG cultures appear to be complementary: HepaRG cells produced 9 additional metabolites, but which appear to be minor in vivo metabolites. Specific* and/or abundant Fu-F metabolites are dihydrodiol-Fu-F*, norFu-F* and despropionylfentanyl. However, norFu-F seems to be inconstantly observed in in vivo cases. Furthermore, a sulfate metabolite presents at significant rate in urine obtained from FU-F users was not identified here, as in another in vitro study.
CONCLUSION: HLMs represent an acceptable first choice tool for a single NPS metabolism study in forensic laboratories. Dihydrodiol-Fu-F and despropionylfentanyl could be proposed as reliable metabolites to be recorded in HRMS libraries in order to improve detection of Fu-F users. Nevertheless, additional verifications of in vivo data remain necessary to confirm relevant blood and urinary metabolites of Fu-F. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Furanyl-fentanyl; HLM; HepaRG; LC-HRMS; NPS; metabolites

Mesh:

Substances:

Year:  2017        PMID: 29173157     DOI: 10.2174/1389201018666171122124401

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  5 in total

1.  Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.

Authors:  Camille Richeval; Jean-Michel Gaulier; Ludovic Romeuf; Delphine Allorge; Yvan Gaillard
Journal:  Int J Legal Med       Date:  2018-11-15       Impact factor: 2.686

Review 2.  Postmortem Toxicology of New Synthetic Opioids.

Authors:  Marta Concheiro; Rachel Chesser; Justine Pardi; Gail Cooper
Journal:  Front Pharmacol       Date:  2018-10-26       Impact factor: 5.810

3.  Untargeted Metabolic Profiling of 4-Fluoro-Furanylfentanyl and Isobutyrylfentanyl in Mouse Hepatocytes and Urine by Means of LC-HRMS.

Authors:  Camilla Montesano; Flaminia Vincenti; Federico Fanti; Matteo Marti; Sabrine Bilel; Anna Rita Togna; Adolfo Gregori; Fabiana Di Rosa; Manuel Sergi
Journal:  Metabolites       Date:  2021-02-10

4.  New insights into quetiapine metabolism using molecular networking.

Authors:  Brendan Le Daré; Pierre-Jean Ferron; Pierre-Marie Allard; Bruno Clément; Isabelle Morel; Thomas Gicquel
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

Review 5.  Recent trends in drugs of abuse metabolism studies for mass spectrometry-based analytical screening procedures.

Authors:  Lea Wagmann; Tanja M Gampfer; Markus R Meyer
Journal:  Anal Bioanal Chem       Date:  2021-04-01       Impact factor: 4.142

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.